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Purpose. To evaluate early changes in visual function and visual quality parameters after Descemet membrane endothelial
keratoplasty (DMEK) and to compare the outcomes with healthy controls.Methods. )irteen patients who underwent DMEK and
14 controls were evaluated. All subjects underwent visual function evaluation, including visual acuity under photopic andmesopic
lighting conditions and contrast sensitivity (CSV) tests CSV 1000 and Pelli-Robson. Corneal parameters were assessed with
Oculus Pentacam. Corneal mean keratometry (Km), corneal densitometry values, and low and high order aberrations (LOA and
HOA) were recorded. In DMEK patients, all tests were performed before surgery and 1 and 6 months after surgery. Results. In
patients who underwent DMEK, photopic visual acuity improved from 0.59 to 0.31 at 1 month (p � 0.013) and 0.13 at 6 months
(p � 0.008); mesopic visual acuity and all contrast sensitivity values (both CSV and Pelli-Robson test) improved significantly in
the first month (p< 0.005). A significant decrease was observed in corneal density in the 0–2mm ring (from 43.83 to 35.60,
p � 0.043) and mean posterior Km (from −5.84 to −6.80, p � 0.005) in the first month. Corneal HOAs and all corneal densities
improved at 6 months after DMEK (p< 0.05). All visual function parameters and corneal aberrations remained lower and higher,
respectively, compared with healthy controls (p< 0.05). Corneal densities were comparable with controls at 6 months after DMEK
(p> 0.05). Conclusions. Patients undergoing DMEK present visual function improvement and a decrease in corneal density at 1
month after surgery. Decrease in corneal posterior HOAs can be observed at 6 months. However, visual function outcomes and
corneal aberrations remained worse compared with healthy controls.
1. Introduction
In the last decade, selective replacement of the diseased
endothelium with a donor endothelial graft has superseded
traditional full-thickness penetrating keratoplasty [1], in the
treatment of endothelial disorders such as Fuchs endothelial
dystrophy and pseudophakic bullous keratopathy. Benefits
of endothelial keratoplasty (EK) over penetrating kerato-
plasty include superior biomechanical integrity, faster visual
recovery with better uncorrected visual acuity, and a more
predictable refractive outcome with less induced astigma-
tism [2–4].
It has been well established that Descemet membrane
endothelial keratoplasty (DMEK) produces better visual
outcomes than other EK techniques.)eories explaining this
improvement in visual results include a more regular pos-
terior graft surface with greater thickness uniformity [5–7],
thinner grafts with a better match in curvature, improved
parallelism between the graft and recipient, and improved
optical compensation by the posterior cornea [8]. )ese
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advantageous structural results might be explained by the
transplantation of only an isolated Descemet membrane and
its endothelium in DMEK, apparently resulting in near-
normal anatomic corneal restoration. )us, it has been
suggested that a transplanted DMEK cornea may approach
the optical quality of a healthy cornea [9].
Corneal aberrations after DMEK have been previously
studied [9, 10]. However, research on visual function (which
overall provide more accurate information on the patient’s
visual performance than high contrast visual acuity) and
other corneal parameters such as corneal light scatter after
DMEK is scarce, and surgery outcomes are mostly compared
with other keratoplasty techniques rather than healthy
controls. )e purpose of the present study was to provide
further and complete information on early changes in visual
function and corneal parameters after DMEK and to
compare visual and structural outcomes with healthy con-
trols. )is is the first longitudinal follow-up study in DMEK
patients including all these visual function tests and den-
sitometry analysis.
2. Methods
)irteen patients who underwent DMEK surgery and 14
healthy controls were included in the study. All procedures
adhered to the tenets of the Declaration of Helsinki, and all
participants provided informed consent to participate in the
study. )e protocol and informed consent were approved by
the local ethics committee for scientific research in Arago´n
(Comite´ E´tico de Investigaciones Cient´ıficas de Arago´n-
CEICA, PI16/0010).
Pseudophakic patients with different stages of corneal
edema secondary to endothelial disease (FED/BK) were se-
lected for the study. )e reason to include only pseudophakic
patients was to avoid any alterations in the visual quality
measurements caused by lens opacifications (cataract of any
kind). DMEK surgery was programmed in all cases. )e
Descemet endothelial grafts were harvested from 13 donor
corneoscleral buttons using the standardized “no touch”
technique for endothelial graft preparation [11]. All DMEK
procedures were carried out following the standardized “no
touch” technique. To summarize, a descemetorhexis was
performed up to 1mm from the limbus under air. An anterior
chamber maintainer (Centurion Vision System, Alcon lab-
oratories Inc.) with continuous air infusion was used to fill the
anterior chamber with air during descemetorhexis.)e donor
Descemet endothelial roll was inserted into the anterior
chamber of the patient with a glass injector after staining with
0.06% trypan blue.)e graft was oriented with the donor DM
facing the recipient posterior stroma and attached onto the
recipient posterior stroma with air. )e anterior chamber was
pressurized with air for 60 to 80 minutes, followed by an air-
fluid exchange leaving a 50% air bubble.
Patients who experienced intraoperative and/or post-
operative complications were excluded from the study.
Complications were defined as any event that could po-
tentially affect visual quality measurements: significant graft
detachment or any detachment causing corneal edema (even
if edema was not affecting the visual axis), the use of corneal
sutures, paralytic mydriasis caused by ischaemia during the
anterior chamber pressurization, the presence of significant
amount of pigment on the intraocular lens, and delayed
epithelial wound healing (more than 3 weeks). Other ex-
clusion criteria were the presence of significant refractive
errors prior to DMEK surgery (>5 diopters of spherical
equivalent refraction or 3 diopters of astigmatism); axial
length >26mm or <22mm; intraocular pressure ≥21mmHg;
media opacifications such as corneal fibrosis, cataract, or
vitreous opacifications; concomitant ocular diseases, in-
cluding history of glaucoma or retinal pathology; and sys-
temic conditions that could affect the visual system. All
controls included in the study were pseudophakic (un-
complicated surgery) and had no history nor evidence of
ocular or neurologic disease of any nature; their best-
corrected visual acuity (BCVA) was >20/30 based on the
Snellen scale. Only one eye per subject was randomly se-
lected in the control group and included. From a total of 20
consecutive patients planned for DMEK, 7 patients were
excluded (2 due to significant detachment that produced
corneal edema for longer than a month; 2 patients were
excluded due to corneal epithelial ulcers with delayed
healing; 1 due to iris ischaemia, 1 due to superficial corneal
fibrosis, and 1 due to fibrotic maculopathy), and their data
(preoperative and postoperative) were withdrawn from the
final statistical analysis.
All patients underwent visual function and visual quality
evaluation before surgery (from 1 week to a maximum of 2
months prior the intervention) and at one and sixmonths after
the DMEK procedure. Controls were evaluated in one visit, at
least 6 months after cataract surgery. Visual function was
assessed in all participants by evaluating BCVA using an Early
Treatment Diabetic Retinopathy Study (ETDRS) chart and
contrast sensitivity vision (CSV) using the Pelli-Robson and
CSV-1000E tests. Structural corneal parameters were evaluated
with the Pentacam® system (OCULUS, Wetzlar, Germany).LogMAR visual acuity (VA) was assessed under mon-
ocular vision with best spectacle correction, in two different
controlled lighting conditions: photopic (85 cd/m2) and
mesopic (3 cd/m2). Contrast sensitivity provides more
complete information about visual function than does visual
acuity tests. CSV was evaluated in our patients using the
Pelli-Robson chart and the CSV-1000E test. )e Pelli-
Robson chart comprises horizontal lines of capital letters
organized into groups of three (triplets) with two triplets per
line.)e contrast decreases from one triplet to the next, even
within each line. All patients were evaluated under mon-
ocular vision at a distance of 1 meter from the chart and
under controlled photopic conditions (85 cd/m2). )e score
corresponding to the last triplet of letters seen by the patient
was recorded.)e CSV-1000E instrument is used worldwide
for standardized CSV and glare testing. All patients were
evaluated at a distance of 2.5 meters from the chart under
monocular vision at 4 different spatial frequencies (3, 6, 12,
and 18 cycles per degree (cpd)), under 3 different lighting
conditions: photopic (85 cd/m2), mesopic (3 cd/m2), and
mesopic with glare (3 cd/m2 + 90/100). )e chart comprises
four rows with 17 circular patches each. )e patches present
a grating that decreases in contrast moving from left to right
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across the row. )e patient indicates whether the grating
appears in the top patch or the bottom patch for each
column. Each contrast value for each spatial frequency was
transformed into a logarithmic scale according to stan-
dardized values.
Corneal quality parameters were evaluated using the
Pentacam® system (OCULUS, Wetzlar, Germany). )isdevice uses a rotational Scheimpflug camera that produces
high-resolution three-dimensional images of the anterior
pole of the eye. It provides different corneal maps (curvature,
refraction, elevation, and pachymetric maps) and calculates
numerical parameters of keratometry. Additionally, the
software calculates corneal densitometry (backscattered
light) in 3 different fixed corneal layers (anterior layer
(anterior 120mm), central layer, and posterior layer (pos-
terior 60mm)), as well as in fixed corneal concentric rings
around the apex (central 0–2mm, 2–6mm, 6–10mm, and
10–12mm) [12].
For this study, central, anterior, and posterior corneal
densitometry (0–2mm zone and total); mean keratometry
(Km); and the root mean square values (RMS) for total, low-
order, and high-order aberrations (LOA and HOA, re-
spectively) were calculated for anterior and posterior cornea
and recorded. LOA include the second-order Zernike
polynomials which represent the conventional aberrations
defocus (myopia, hyperopia, and astigmatism). )ese ab-
errations represent 85% of total aberrations in the eye. HOA
describe Zernike aberrations above second-order: third-
order Zernike terms are coma and trefoil; fourth-order
Zernike terms include spherical aberration. Higher-order
aberrations make up about 15% of the overall number of
aberrations in an eye and cannot be corrected by any means
of present technology. Central corneal thickness and en-
dothelial cell density at 6 months were also measured in our
patients.
All data analyses were performed using SPSS software
version 20.0 (SPSS Inc., Chicago, IL). To monitor the pro-
gression of corneal changes after DMEK, visual function and
visual quality parameters were compared within the patients
groups: preoperative data were compared with data obtained
at one month after surgery, and the latter were compared
with measurements obtained at 6 months after DMEK. To
evaluate the differences between corneas which underwent
DMEK surgery and healthy corneas, parameters obtained at
6 months after DMEK in patients were compared with
measurements obtained in controls. Due to the non-
parametric distribution of the data, comparisons between
the different groups were calculated using the Mann–
Whitney U test. A correlation analysis between visual
function and topographic parameters was performed using
Spearman’s Rho test. A level of significance was considered
at p< 0.05. To avoid a high false-positive rate, the Bonferroni
correction for multiple tests was calculated, and the cor-
rected p values were added to the previously calculated data.
3. Results
A total of 13 eyes in 13 different patients who underwent
DMEK surgery and 14 eyes of 14 healthy controls were
included in the study. Mean age in the patients group was
69.45± 7.51 years and in the control group was 72.62± 9.38
years (p � 0.296). Mean axial length was 23.58± 1.74mm in
the DMEK group and 23.47± 1.25mm in the control group
(p � 0.722). Anterior and posterior keratometric values
were similar between both groups (p � 0.841 and p � 0.080,
respectively). )e indication for DMEK was Fuchs endo-
thelial dystrophy (n� 8), bullous keratopathy (n� 2), or both
(n� 3). At 6 months postoperative, mean central corneal
thickness in patients was 507± 36 microns, and mean en-
dothelial cell density was 912± 326 cells/mm2.
3.1. Improvement of Visual and Corneal Parameters after
DMEK. Patients who underwent DMEK experienced
a significant improvement in all visual function parameters
at one month after surgery (Table 1). After the first post-
operative month, all parameters continued to improve.
However, only photopic BCVA (0.31± 0.19 at 1 month vs
0.13± 0.09 at 6 months, p � 0.008), CSV at 6 cpd under
mesopic conditions + glare (1.06± 0.58 at 1 month vs 1.46±
0.33 at 6 months, p � 0.034), and CSV as measured with the
Pelli-Robson chart (1.29± 0.18 at 1 month vs 1.48± 0.14 at 6
months, p � 0.006) improved significantly at 6 months
(Table 1).
A significant decrease of the 0–2mm density both in the
anterior (43.83± 10.50 preoperative vs 35.60± 12.16 at 1
month postoperative, p � 0.045) and posterior cornea
(27.70± 4.20 vs 22.07± 7.45, p � 0.006) was observed at one
month after DMEK. A significant improvement of the
posterior Km was also observed at 1 month after surgery
(−5.84± 0.23 preoperative vs −6.80± 0.67 at 1 month
postoperative, p � 0.005). Total corneal densities and pos-
terior aberrations (LOA and total) also improved compared
with preoperative levels without reaching significance.
Posterior HOA did not change within the first month. A
significant increase in the anterior corneal aberrations was
observed at 1 month after DMEK (RMS LOA, 3.36± 1.23
preoperative vs 4.73± 1.67 at 1 month, p � 0.026; RMS total
aberrations, 3.60± 1.28 vs 5.04± 1.77, p � 0.022) (Table 2).
Central corneal density (33.60± 13.87 at 1 month vs
24.32± 2.92 at 6 months, p � 0.006), all anterior corneal
densities (0–2, 35.60± 12.16 vs 25.21± 5.40, p � 0.035; total,
38.40± 10.03 vs 29.25± 6.52 p � 0.029), posterior 0–2mm
density (22.07± 7.45 vs 17.60± 2.83, p � 0.010), and all
posterior aberrations continued to decrease significantly at 6
months (RMS HOA, 0.69± 0.26 vs 0.47± 0.13, p � 0.015;
RMS LOA, 1.54± 0.56 vs 1.04± 0.29, p � 0.020; RMS total
1.71± 0.57 vs 1.15± 0.29, p � 0.015). Anterior corneal ab-
errations decreased at 6 months compared with 1 month
after surgery. However, the differences did not reach sig-
nificance levels (Table 2).
A representative case of preoperative-postoperative
changes after DMEK can be seen in Figure 1.
3.2. Comparison between DMEK Corneas and Healthy
Corneas. Compared with healthy subjects, patients who
underwent DMEK presented worse visual function at 6
months after DMEK, in all parameters except the CSV at 3
Journal of Ophthalmology 3
cpd (photopic, p � 0.676; mesopic, p � 0.064 and mesopic
+ glare, p � 0.786) (Table 3).
No significant differences were observed between DMEK
corneas at 6 months after surgery and healthy corneas in the
central, anterior, and posterior corneal densitometry and in
the anterior and posterior Km values (p> 0.05) (Table 4).
Anterior (HOA, 1.50± 1.11 in patients vs 0.76± 0.21 in
controls, p � 0.021 and total 4.39± 2.23 vs 2.54± 0.74,
p � 0.014) and posterior (HOA, 0.47± 0.13 in patients vs
0.25± 0.10 in controls, p< 0.001; LOA, 1.04± 0.29 vs 0.67±
0.33, p � 0.005 and total, 1.15± 0.29 vs 0.72± 0.34,
p � 0.002) aberrations remained higher in the group of
DMEK patients compared with healthy controls (Table 4).
)e correlation analysis did not reveal any significant
association between visual function parameters and to-
pographical changes in DMEK patients. An additional
analysis was performed over a selected group of 8 patients
who presented better visual results (BCVA≤0.1), and
anterior and posterior HOAs were compared with con-
trols. Patients with good visual outcomes 6 months after
DMEK presented higher posterior HOAs compared with
controls (0.62 ± 0.30 in DMEK vs 0.26 ± 0.11 in controls,
p � 0.001). However, though higher, no significant dif-
ferences were observed in anterior HOAs between both
groups (1.49 ± 0.70 in DMEK vs 0.78 ± 0.22 in controls,
p � 0.065).
Table 1: Visual function parameters in patients undergoing DMEK asmeasured preoperative and at 1month and at 6months postoperative.
Functional
parameter Preoperative
1 month
postoperative
P (preoperative vs 1
month postoperative)
6 month
postoperative P (1 month vs 6 months postoperative)
Visual Acuity
VA ETDRS photopic 0.59 (0.33) 0.31 (0.19) 0.013 0.13 (0.09) 0.008
VA ETDRS mesopic 0.75 (0.25) 0.50 (0.22) 0.012 0.36 (0.15) 0.130
Contrast sensitivity
CSV 3cpd 0.46 (0.52) 1.06 (0.61) 0.005 1.49 (0.45) 0.077
CSV 6cpd 0.23 (0.52) 1.17 (0.65) <0.001∗ 1.33 (0.47) 0.363
CSV12cpd 0.21 (0.41) 0.58 (0.50) 0.031 0.80 (0.46) 0.217
CSV18cpd 0.08 (0.18) 0.29 (0.31) 0.015 0.45 (0.46) 0.264
CSV-M 3cpd 0.44 (0.48) 1.20 (0.48) 0.001∗ 1.52 (0.28) 0.056
CSV-M 6cpd 0.19 (0.44) 1.19 (0.55) <0.001∗ 1.26 (0.66) 0.401
CSV-M 12cpd 0.13 (0.31) 0.71 (0.67) 0.004 0.76 (0.56) 0.741
CSV-M 18cpd 0.07 (0.18) 0.23 (0.30) 0.022 0.34 (0.28) 0.350
CSV-MG 3cpd 0.21 (0.45) 1.06 (0.58) 0.001∗ 1.46 (0.33) 0.034
CSV-MG 6cpd 0.12 (0.35) 0.83 (0.57) <0.001∗ 0.84 (0.64) 0.867
CSV-MG 12cpd 0.04 (0.15) 0.43 (0.39) 0.001∗ 0.59 (0.56) 0.434
CSV-MG 18cpd 0.05 (0.35) 0.27 (0.33) 0.002∗ 0.34 (0.28) 0.755
Pelli-Robson 1.00 (0.29) 1.29 (0.18) 0.005 1.48 (0.14) 0.006
P values correspond to comparisons preoperative versus 1 month and 1 month versus 6 months. Bold letters indicate p< 0.05. Asterisks mark Bonferroni
values less than 0.003. DMEK, Descemet membrane endothelial keratoplasty; VA, visual acuity; ETDRS, Early Treatment Diabetic Retinopathy Study; CSV,
contrast sensitivity vision; cpd, cycles per degree.
Table 2: Visual quality parameters as obtained with Oculus Pentacam of corneas undergoing Descemet membrane endothelial keratoplasty
(DMEK) measured preoperative and at 1 month and at 6 months postoperative.
Quality
parameter Preoperative
1 month
postoperative
P (preoperative vs 1
month postoperative) 6 months postoperative P (1 month vs 6 months postoperative)
Anterior cornea
Central density 39.81 (10.99) 33.60 (13.87) 0.069 24.32 (2.92) 0.006∗
0–2mm density 43.83 (10.50) 35.60 (12.16) 0.045 25.21 (5.40) 0.035
Total density 41.06 (10.43) 38.40 (10.03) 0.489 29.25 (6.52) 0.029
Km 43.83 (2.03) 43.13 (1.86) 0.281 42.85 (1.50) 0.607
RMS HOA (µm) 1.19 (0.52) 1.66 (0.79) 0.249 1.50 (1.11) 0.317
RMS LOA (µm) 3.36 (1.23) 4.73 (1.67) 0.026 3.86 (2.24) 0.427
RMS total (µm) 3.60 (1.28) 5.04 (1.77) 0.022 4.39 (2.23) 0.522
Posterior cornea
0–2mm density 27.70 (4.20) 22.07 (7.45) 0.006∗ 17.60 (2.83) 0.010
Total density 29.06 (4.56) 26.26 (5.44) 0.214 23.38 (3.52) 0.128
Km −5.84 (0.23) −6.80 (0.67) 0.005∗ −6.52 (0.39) 0.217
RMS HOA (µm) 0.69 (0.34) 0.69 (0.26) 0.828 0.47 (0.13) 0.015
RMS LOA (µm) 1.71 (1.08) 1.54 (0.56) 0.870 1.04 (0.29) 0.020
RMS total (µm) 1.86 (1.11) 1.71 (0.57) 0.703 1.15 (0.29) 0.015
Bold letters indicate p< 0.05. Asterisk marks Bonferroni values <0.007. DMEK, Descemet membrane endothelial keratoplasty; Km, mean keratometry; RMS,
root mean square; HOA, high-order aberrations; LOA, low-order aberrations; µm, microns.
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(a)
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After 6 months
(c) Pachymetric map Total keratometry Posterior keratometry
(b)
Preoperative
6 months
1 month
0.05
0.35
0.65
0.95
1.25
1.55
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0.20
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2.00
2.30
Figure 1: Representative case of a patient included in the study, who underwent DMEK. (a) Preoperative (left) and 1 month postoperative
(right) slitlamp image of the right eye of a 62-year-old female patient who underwent DMEK. (b) Contrast sensitivity results: left, CSV 1000
test results marked with discontinuous-continuous circled lines (see legend in the figure); in frequencies B, C, and D, no preoperative circle
was marked since the patient could not even identify the first image; right, Pelli-Robson results at preoperative and 1 month and 6 months
postoperative. (c) Topographic changes preoperative and at 6 months postoperative: left, corneal thickness map; center, keratometric map of
the frontal cornea; right, keratometric map of the posterior cornea.
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3.3. Discussion. In the present study, we evaluated early
visual rehabilitation and progressive corneal changes in 13
eyes which underwent DMEK surgery and compared them
with a group of healthy subjects. Research on visual and
corneal changes after DMEK typically focused on the out-
comes at six months postoperative [9, 10, 13]. Despite
published studies by the Melles team on early outcomes
after DMEK, these results refer mainly to BCVA in phot-
opic conditions [14, 15]. Measuring BCVA and contrast
sensitivity in different lighting conditions may provide more
accurate information about the visual system and the pa-
tient’s possible performance in everyday situations (such as
driving and reading) [16, 17]. Our patients’ visual function
(photopic and mesopic BCVA and CSV) improved dra-
matically after surgery, and most of the measured param-
eters stabilized at 1 month after the procedure. BCVA in
photopic conditions additionally improved significantly at 6
months. Improvement in light scattering (both anterior and
posterior) and posterior mean keratometry was observed in
the first month. However, posterior HOA did not decrease
until six months after surgery. Anterior HOAs did not
change after DMEK in our patients.
Despite the observed changes and early improvement
after DMEK, visual function at 6months was worse than that
in controls (except CSV in the 3 cpd frequency), and corneal
HOA remained higher in patients than in healthy controls.
)ese results support previous studies in which contrast
sensitivity and posterior aberrations in eyes undergoing
DMEK did not reach the same levels as controls [9, 13].
Garrido et al. demonstrated that CSV (as measured with the
Pelli-Robson test) in pseudophakic patients undergoing
DMEK remained worse than CSV in phakic healthy con-
trols. Additionally, CSV 1000 test was used by Garrido et al.
to assess CSV after DMEK and compare the results with
other keratoplasty techniques [18]. DMEK demonstrated to
preserve better CSV at 12 and 18 cpd compared with other
procedures. However, these outcomes were never compared
with a healthy population. Despite the numerous published
articles on DMEK visual outcomes, we could not find any
study performing a complete evaluation of visual function
parameters (that is, measuring BCVA and CSV at different
spatial frequencies and lighting situations) in DMEK pa-
tients compared with healthy controls. )e present study
provides not only a complete analysis of visual function
changes after DMEK but also compares visual outcomes
with a healthy population in similar circumstances.
Previous research by Van Dijk et al demonstrated that
DMEK corneas presented a significant decrease in posterior
HOA at six months after surgery, but as it was also observed
in our patients, these aberrations remained higher compared
with controls [9]. Rudolph et al. demonstrated that DMEK
corneas presented higher HOA in the posterior 4mm of the
cornea compared to healthy eyes [10]. However, they failed
to detect changes in anterior HOA and LOA, whereas van
Dijk et al. found higher anterior HOA in their patients
compared with controls [9]. Increased anterior and posterior
HOAs were also observed recently in the 6mm central
cornea, in DMEK patients compared with controls [19]. Our
patients did not experience any significant changes in an-
terior HAO; however, anterior LOA increased significantly
in the first month, contrary to that observed by van Dijk et al.
and Rudolph et al. [9, 10]. HOAs have been correlated to
visual acuity after EK and PKP due to the degradation by
HOAs of the small-angle domain of the retinal point-spread
function [7, 19]. Posterior corneal HOAs increased after EK
compared with healthy controls [19–23], and it has been
suggested that the posterior corneal surface is the source
of increased whole-eye HOAs after Descemet stripping
Table 3: Visual function parameters in patients undergoing
Descemet membrane endothelial keratoplasty (DMEK) at 6
months postoperative compared with healthy corneas.
Functional parameter DMEK Controls p
Visual Acuity
VA ETDRS photopic 0.13 −0.15 0.002∗
VA ETDRS mesopic 0.36 0.23 0.044
Contrast sensitivity
CSV 3cpd 1.49 1.62 0.676
CSV 6cpd 1.33 1.79 <0.001∗
CSV 12cpd 0.80 1.39 0.006
CSV 18cpd 0.45 0.95 0.006
CSV-M 3cpd 1.52 1.72 0.064
CSV-M 6cpd 1.26 1.81 0.005
CSV-M 12cpd 0.76 1.46 0.001∗
CSV-M 18cpd 0.34 0.94 <0.001∗
CSV-MG 3cpd 1.46 1.61 0.786
CSV-MG 6cpd 0.84 1.63 0.001∗
CSV-MG 12cpd 0.59 1.33 0.001∗
CSV-MG 18cpd 0.39 1.10 0.002∗
Pelli-Robson 1.48 1.71 0.002∗
Bold letters indicate p< 0.05. Asterisks mark Bonferroni values less than
0.003. DMEK, Descemet membrane endothelial keratoplasty; VA, visual
acuity; ETDRS, Early Treatment Diabetic Retinopathy Study; CSV, contrast
sensitivity vision; cpd, cycles per degree.
Table 4: Visual quality parameters as obtained with Oculus
Pentacam of corneas undergoing Descemet membrane endothelial
keratoplasty (DMEK) at six months after surgery compared with
healthy controls.
Quality parameter DMEK Controls p
Anterior cornea
Central density 24.32 (2.92) 23.84 (9.87) 0.099
0–2mm density 25.21 (5.40) 29.83 (9.30) 0.275
Total density 29.25 (6.52) 36.35 (9.54) 0.052
Km 42.85 (1.50) 44.15 (1.77) 0.058
RMS HOA (µm) 1.50 (1.11) 0.76 (0.21) 0.021
RMS LOA (µm) 3.86 (2.24) 2.42 (0.73) 0.069
RMS total (µm) 4.39 (2.23) 2.54 (0.74) 0.014
Posterior cornea
0–2mm density 17.60 (2.83) 18.46 (6.51) 0.734
Total density 23.38 (3.52) 26.72 (6.33) 0.234
Km −6.52 (0.39) −6.36 (0.24) 0.292
RMS HOA (µm) 0.47 (0.13) 0.25 (0.10) <0.001
RMS LOA (µm) 1.04 (0.29) 0.67 (0.33) 0.005
RMS total (µm) 1.15 (0.29) 0.72 (0.34) 0.002
Central density has been included in the anterior corneal measurements
group. Bold letters indicate p< 0.05. DMEK, Descemet membrane endo-
thelial keratoplasty; Km, mean keratometry; RMS, root mean square; HOA,
high-order aberrations; LOA, low-order aberrations; µm, microns.
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endothelial keratoplasty (DSEK) compared with normal eyes
[21, 24]. Posterior HOAs have been linked to BCVA after EK
[19]; however, several studies have failed to find an asso-
ciation between posterior corneal HOAs and postoperative
BCVA [9, 23, 25, 26], leading some authors to suggest that
changes in the posterior cornea should not affect visual
acuity [21, 27]. Anterior HOAs have been found to be higher
after DSAEK than in normal corneas [28], and a significant
correlation has been demonstrated between anterior corneal
HOAs and postoperative BCVA [10, 22, 23]. Since EK itself
causes minimal disruption of the anterior corneal surface, it
is reasonable to suggest that other sources (that is, other than
the surgical technique) of increased HOAs must exist in
these patients, such as factors related to the underlying
disease. In our patients, anterior HOAs after DMEK
remained higher than in controls, and a significant increase
in anterior LOAs was observed in the first month, whereas
visual function and corneal densities improved. )ese ob-
served changes might be due to preexistent chronic stromal
edema, degeneration of keratocytes, and collagen re-
organization after DMEK. Additionally, when our patients
with better visual outcomes were analysed separately, no
differences in anterior HOAs were observed compared with
controls. )is might also suggest that anterior HOAs play
a more important role concerning BCVA results in these
patients than do posterior HOAs. )ese results should still
be analysed with caution due to the small sample size and the
limitation to the statistical calculations.
)ough corneal aberrations have been widely studied
after EK, literature on light scattering after DMEK is scarce.
We could only find one published study in which corneal
density after DMEK was analysed and compared with
healthy corneas [9]. In their study, Van Dijk et al. found
a strong significant correlation between anterior corneal
haze and postoperative BCVA.
It has been argued that light scatter alone cannot affect
high-contrast visual acuity [6, 29]. However, increased light
scatter may reduce visual quality after EK [29–31], and this is
more evident in everyday low-contrast situations [21]. )e
anterior recipient cornea has been proved to be the main
source of haze after other EK techniques such as DSEK and
deep lamellar endothelial keratoplasty [6, 29]. Changes as-
sociated with this stromal haze seem to be independent of
preoperative edema or fibrosis [32]. In our patients, corneal
0–2mm anterior and posterior densities decreased signifi-
cantly in the first month after DMEK.)ese early changes in
light scattering had not been documented before since most
DMEK studies evaluate their outcomes at 6 months after the
procedure. All densities in our patients improved at 6
months after surgery reaching similar light scattering levels
to healthy corneas. However, visual function outcomes
remained worse than controls, suggesting that other factors
such as anterior and posterior HOAs may be limiting
postoperative visual quality outcomes in our patients. Our
results differ from previous observations on light scattering
after DMEK, where corneal densities at 6 months post-
operative remained higher than those in healthy corneas.
More studies evaluating changes in corneal density after
DMEK are needed to corroborate our findings.
)e most important limitation to our study is the small
sample size, which may be limiting the statistical findings.
We believe that correlations between visual results and
corneal parameters were not observed in our study due to
the small sample size, and further studies analysing visual
function with a larger number of patients are needed to
establish a correlation between BCVA and CSV and topo-
graphic changes in these patients. Given the large samples
included in other studies (especially those from the Melles
group), our study should be interpreted with caution when
compared with other similar research studies, and factors
responsible for visual function outcomes in our patients
cannot be taken further from speculation.
4. Conclusions
Patients undergoing DMEK present visual function im-
provement and a decrease in anterior and posterior corneal
density at 1 month after the procedure. A further decrease in
corneal posterior HOAs was observed at 6 months. Despite
this remarkable improvement, visual function outcomes
remained worse compared with healthy corneas. Corneal
parameters such as mean keratometry and corneal density
were comparable to controls; however, HOAs remained
higher in DMEK patients at 6 months after surgery. Similar
studies with a larger simple size are needed in order to
establish a possible correlation between visual function
outcomes and corneal parameters after DMEK.
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